Cochlear Implants and Auditory Brainstem Implants 7.01.26
Summary
Excellus BlueCross BlueShield medical policy 7.01.26 covers cochlear implants and auditory brainstem implants and states when each is considered medically appropriate. Unilateral and bilateral cochlear implants are considered appropriate for bilateral severe-to-profound sensorineural hearing loss when all listed criteria are met, including a pure-tone average above 70 dB HL at 500, 1000 and 2000 Hz and limited or no benefit from appropriately fit hearing aids. The policy also covers unilateral implants for single-sided deafness or asymmetric hearing loss, hybrid cochlear implants, auditory brainstem implants for neurofibromatosis type 2, and repair and replacement of devices. The current effective date is March 19, 2026, and the April 22, 2026 edit added reference resources.
Get alerts when payers change rules like this one
We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.